Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer

NCT00660842 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

PROCEDURE: carboplatin
DRUG: paclitaxel
DRUG: carboplatin
DRUG: paclitaxel

Sponsor

National Cancer Institute, Naples